Cabot Corp: (NYSE: CBT)

$40.14

-0.61 (-1.50%)

Volume 691,281

May 22 04:01 PM ET

Zacks Rank: 5-Strong Sell

 
 
 
 
#5

Full Company Report

Get Full Company Report for:

Cabot Corporation is a global specialty chemicals and materials company. Cabot's major products are carbon black, fumed silica, inkjet colorants, and aerogels. Cabot has manufacturing plants located in countries around the world. (Company Press Release)

General Information

CABOT CORP
TWO SEAPORT LANE SUITE 1300
BOSTON, MA 82109
Phone: 6173450100
Fax: 617-342-6103
Web: http://www.cabot-corp.com
Email: Erica.mclaughlin@cabotcorp.com

Industry CHEM-DIVERSIFD
Sector Basic Materials
Fiscal Year End September
Last Reported Quarter 03/31/2013
Next EPS Date 08/06/2013

Price and Volume Information

Zacks Rank
Yesterday's Close 40.75
52 Week High 44.16
52 Week Low 32.13
Beta 1.74
20 Day Moving Average 418,744.75
Target Price Consensus 46.71

% Price Change

4 Week 15.97
12 Week 12.20
YTD 0.18

Share Information

Shares Outstanding (millions) 63.78
Market Capitalization (millions) 2,598.87
Short Ratio 2.28
Last Split Date 03/25/96

CBT

% Price Change Relative to S&P 500

4 Week 9.69
12 Week 0.62
YTD -13.24

Dividend Information

Dividend Yield 1.96%
Annual Dividend $0.80
Payout Ratio 0.27
Change in Payout Ratio -0.80
Last Dividend Payout / Amount 02/27/2013 / $0.20

EPS Information

Current Quarter EPS Consensus Estimate 0.91
Current Year EPS Consensus Estimate 3.01
Estimated Long-Term EPS Growth Rate 10.00
Next EPS Report Date 08/06/2013

Consensus Recommendations

Current (1=Strong Buy, 5=Strong Sell) 1.83
30 Days Ago 1.71
60 Days Ago 1.71
90 Days Ago 1.71

Fundamental Ratios

P/E

Current FY Estimate 13.55
Trailing 12 Months 13.86
PEG Ratio 1.35

Price Ratios

Price/Book 1.33
Price/Cash Flow 6.90
Price / Sales 0.77

Current Ratio

03-31-13 1.58
12-31-12 1.78
09-30-12 1.57

Net Margin

03-31-13 4.48
12-31-12 10.82
09-30-12 11.80

Inventory Turnover

03-31-13 5.23
12-31-12 5.54
09-30-12 5.96

EPS Growth

vs. Previous Year -33.33%
vs. Previous Quarter 16.36%
   

ROE

03-31-13 9.76
12-31-12 10.96
09-30-12 11.69

Quick Ratio

03-31-13 1.04
12-31-12 1.04
09-30-12 0.99

Pre-Tax Margin

03-31-13 5.69
12-31-12 6.88
09-30-12 7.42

Debt-to-Equity

03-31-13 0.51
12-31-12 0.63
09-30-12 0.60

Sales Growth

vs. Previous Year -0.24%
vs. Previous Quarter 2.68%
   

ROA

03-31-13 4.58
12-31-12 5.40
09-30-12 6.00

Operating Margin

03-31-13 5.63
12-31-12 6.26
09-30-12 6.49

Book Value

03-31-13 30.58
12-31-12 31.02
09-30-12 30.63

Debt to Capital

03-31-13 33.94
12-31-12 38.66
09-30-12 37.67

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.